Yazdi Zhinous Shahidzadeh, Streeten Elizabeth A, Whitlatch Hilary B, Montasser May E, Beitelshees Amber L, Taylor Simeon I
Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
medRxiv. 2024 Mar 7:2023.06.27.23291942. doi: 10.1101/2023.06.27.23291942.
The body has evolved homeostatic mechanisms to maintain free levels of Ca and 1,25-dihydroxyvitamin D [1,25(OH)D] within narrow physiological ranges. Clinical guidelines emphasize important contributions of PTH in maintaining this homeostasis.
To investigate mechanisms of homeostatic regulation of vitamin D (VitD) metabolism and to apply mechanistic insights to improve clinical assessment of VitD status.
Crossover clinical trial studying participants before and after VitD3-supplementation.
Community.
11 otherwise healthy individuals with VitD-deficiency (25-hydroxyvitamin D [25(OH)D] ≤20 ng/mL).
VitD3-supplements (50,000 IU once or twice a week depending on BMI, for 4-6 weeks) were administered to achieve 25(OH)D≥30 ng/mL.
VitD3-supplementation significantly increased mean 25(OH)D by 2.7-fold and 24,25-dihydroxyvitamin D [24,25(OH)D] by 4.3-fold. In contrast, mean levels of PTH, FGF23, and 1,25(OH)D did not change. Mathematical modeling suggested that 24-hydroxylase activity was maximal for 25(OH)D≥50 ng/mL and achieved a minimum (~90% suppression) with 25(OH)D<10-20 ng/mL. The 1,25(OH)D/24,25(OH)D ratio better predicted modeled 24-hydroxylase activity () (ρ=-0.85; p=0.001) compared to total plasma 25(OH)D (ρ=0.51; p=0.01) and the 24,25(OH)D/25(OH)D ratio (ρ=0.37; p=0.3).
Suppression of 24-hydroxylase provides a first line of defense against symptomatic VitD-deficiency by decreasing metabolic clearance of 1,25(OH)D. The 1,25(OH)D/24,25(OH)D ratio provides a useful index of VitD status since it incorporates 24,25(OH)D levels and therefore, provides insight into 24-hydroxylase activity. When VitD availability is limited, this suppresses 24-hydroxylase activity - thereby decreasing the level of 24,25(OH)D and increasing the 1,25(OH)D/24,25(OH)D ratio. Thus, an increased 1,25(OH)D/24,25(OH)D ratio signifies triggering of homeostatic regulation, which occurs at early stages of VitD-deficiency.
人体已进化出稳态机制,以将钙和1,25 - 二羟基维生素D [1,25(OH)D]的游离水平维持在狭窄的生理范围内。临床指南强调了甲状旁腺激素(PTH)在维持这种稳态中的重要作用。
研究维生素D(VitD)代谢的稳态调节机制,并将机制性见解应用于改善VitD状态的临床评估。
对补充维生素D3前后的参与者进行交叉临床试验。
社区。
11名其他方面健康但维生素D缺乏(25 - 羟基维生素D [25(OH)D]≤20 ng/mL)的个体。
给予维生素D3补充剂(根据体重指数每周一次或两次,每次50,000 IU,持续4 - 6周),以使25(OH)D≥30 ng/mL。
补充维生素D3后,平均25(OH)D显著增加2.7倍,24,25 - 二羟基维生素D [24,25(OH)D]增加4.3倍。相比之下,PTH、成纤维细胞生长因子23(FGF23)和1,25(OH)D的平均水平没有变化。数学模型表明,对于25(OH)D≥50 ng/mL,24 - 羟化酶活性最高,而当25(OH)D<10 - 20 ng/mL时,活性达到最低水平(约90%抑制)。与总血浆25(OH)D(ρ = 0.51;p = 0.01)和24,25(OH)D/25(OH)D比值(ρ = 0.37;p = 0.3)相比,1,25(OH)D/24,25(OH)D比值能更好地预测模型中的24 - 羟化酶活性(ρ = -0.85;p = 0.001)。
抑制24 - 羟化酶通过降低1,25(OH)D的代谢清除率,为预防有症状的维生素D缺乏提供了第一道防线。1,25(OH)D/24,25(OH)D比值提供了一个有用的维生素D状态指标,因为它纳入了24,25(OH)D水平,因此能深入了解24 - 羟化酶活性。当维生素D供应有限时,这会抑制24 - 羟化酶活性,从而降低24,25(OH)D水平并增加1,25(OH)D/24,25(OH)D比值。因此